Why Is the FTC Blocking Merger of Two Cancer Fighters?

Cancer-detection companies Illumina and its former start-up, Grail, say they can save lives and reduce costs through a vertical re-merger. However, regulators on both sides of the Atlantic - the U.S. Federal Trade Commission and the European Commission (EC) - disagree, opposing the merger. Read Full Article »